Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Jäntti, Pauliina
DOB: 31-DEC-1988 (Age: 36)
Gender: female
Address:
Ranna 57
41534 Kohtla-Järve (Estonia)
ID: 8003-808788-0
Report
Date: 29-JUN-2023
Laboratory
dr Ample, Ex
Boulevard du Jardin Botanique 32
1000 Brussels
Requested by
Poliklinnik
Nooruse 3
41536 Jõhvi (Estonia)
Specimen
Collected: 28-JUN-2023

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 28 Jun 2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 290.2 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 117.6 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 213.6 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 53.1 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient has persistent and significantly elevated total and LDL cholesterol over several years, indicating high cardiovascular risk. Triglycerides and HDL are within normal limits. Mildly low hematocrit and high platelet distribution width were noted in 2020, but other blood counts are unremarkable. Lipid management and cardiovascular risk assessment are strongly recommended.